Adams Apple Reshaping Surgery: Benefits & Risks — Cost, Top Hospitals & Success Rates | MyMedicPlus

Adams apple reshaping, medically termed chondrolaryngoplasty or tracheal shave, is a surgical procedure that reduces the prominence of the thyroid cartilage forming the laryngeal prominence (colloquially known as the Adam's apple) in the anterior neck. The thyroid cartilage is the largest cartilage of the larynx and reaches its characteristic visible prominence in males during puberty under androgenic stimulation. While variable in expression, a prominent thyroid cartilage is a recognised masculine secondary sex characteristic, and its reduction is a key component of facial feminisation surgery (FFS) for transgender women, as well as an elective aesthetic procedure for cisgender men who feel self-conscious about their prominent larynx.

The procedure involves making a small incision — typically in a horizontal skin crease of the anterior neck to maximise scar camouflage — dissecting through the platysma and strap muscles to expose the thyroid cartilage, and removing the anterosuperior portion of the cartilage prominence using a burr, scalpel, or electrocautery while carefully preserving the vocal cords and their anterior commissure attachment to the internal surface of the cartilage. Preservation of the anterior commissure is critical to maintaining the patient's existing voice pitch; violation of this structure causes a permanent change in vocal cord vibration and pitch alteration.

Preoperative assessment includes flexible fibreoptic laryngoscopy to characterise the anatomy of the anterior commissure relative to the cartilage ridge, CT imaging to evaluate cartilage calcification (which affects surgical difficulty), and voice assessment. The safe zone of cartilage removal lies above the anterior commissure attachment; the surgeon must identify this anatomical landmark precisely, often facilitated by laryngoscopic monitoring during the procedure. Chondrolaryngoplasty may be combined with other facial feminisation procedures (brow bossing reduction, rhinoplasty, jaw contouring) in a single anaesthetic session when part of a comprehensive FFS plan.

The primary indication for tracheal shave is gender dysphoria in transgender women seeking feminisation of the neck contour as part of facial feminisation surgery. A prominent Adams apple is a highly visible masculine feature that causes significant distress for many transgender women and gender non-conforming individuals, interfering with gender expression and contributing to social dysphoria. Chondrolaryngoplasty is recognised in the WPATH Standards of Care as a feminising surgical procedure for appropriately assessed transgender women.

Secondary aesthetic indications include cisgender men who experience significant distress from an overly prominent thyroid cartilage, affecting their self-image and social confidence. The procedure is also occasionally performed as a component of voice feminisation surgery packages alongside glottoplasty (pitch-raising surgery) in transgender women seeking both anatomical and acoustic feminisation. In rare cases, excessively large thyroid cartilages causing dysphagia or neck discomfort from external pressure are addressed by partial chondrolaryngoplasty for functional relief.

Ideal candidates for tracheal shave are adults with a prominent thyroid cartilage who seek neck feminisation as part of gender-affirming care or for aesthetic reasons, who understand the procedure's limitations and realistic outcomes, and who are medically fit for the chosen anaesthetic approach. For transgender women, candidates should have received gender dysphoria assessment and mental health support as recommended by the WPATH Standards of Care, though chondrolaryngoplasty (unlike gonadal surgery) does not require letters of recommendation under the most recent WPATH SOC 8.

Contraindications include active laryngeal or pharyngeal infection, history of prior laryngeal surgery or trauma creating scarring or abnormal anatomy, significant voice pathology requiring prior laryngological assessment, uncontrolled hypothyroidism (the thyroid gland lies immediately below the surgical field), and active tobacco smoking (increases wound healing risk and anaesthetic complications). Patients with extremely calcified thyroid cartilage (common in older men) present greater surgical challenge, as calcified cartilage is harder to reduce and carries a higher risk of cartilage fracture. Patients with unrealistic expectations of transformation beyond what cartilage reduction can achieve are carefully counselled preoperatively.

The standard approach to chondrolaryngoplasty uses a transverse anterior cervical skin crease incision of 2–4 cm overlying the thyroid cartilage. The incision is placed in a natural skin fold to maximise scar camouflage. Dissection proceeds through platysma to expose the thyroid cartilage surface, displacing the strap muscles laterally. The superior border of the anterior commissure is identified by direct visualisation or fibreoptic laryngoscopy, and cartilage above this level is reduced using a burr, scalpel, or electrocautery. The skin is closed with absorbable sutures in the platysma and subcuticular sutures in the skin.

An alternative endoscopic approach uses small cervical incisions with endoscopic instruments to reduce blood loss and improve cosmetic outcome, though it provides less direct visualisation of the resection zone. Some surgeons perform the procedure under local anaesthesia with sedation (awake technique), which allows intraoperative voice testing to confirm vocal cord integrity — an important safety advantage. Others perform with direct laryngoscopy under general anaesthesia. The amount of cartilage that can safely be removed is limited by the position of the anterior commissure, typically allowing reduction of 30–50% of the visible prominence. In patients requiring significant voice feminisation, chondrolaryngoplasty may be combined in the same session with Wendler glottoplasty (web formation at the anterior commissure to raise pitch).

Chondrolaryngoplasty reliably achieves significant, lasting reduction in thyroid cartilage prominence. The vast majority of patients (85–95%) report satisfaction with the anatomical outcome. Objective measurements confirm reduction of the visible laryngeal prominence of 30–60%, which substantially softens the neck contour. Wound scars placed in natural skin folds are typically barely visible at six to twelve months. Most patients notice an immediate visible reduction in neck prominence that persists long-term as the thyroid cartilage does not regenerate.

For transgender women undergoing facial feminisation surgery, chondrolaryngoplasty contributes meaningfully to overall gender affirmation and is associated with significant improvements in gender dysphoria scores, quality of life, and social confidence. When performed with appropriate respect for the anterior commissure anatomy, voice pitch and quality are maintained unchanged. The procedure's combination of modest surgical duration, day-case or overnight stay, and rapid recovery makes it one of the most favourably risk-benefit balanced components of facial feminisation surgery.

The most feared complication of tracheal shave is inadvertent injury to the anterior commissure — the attachment point of the vocal folds to the internal surface of the thyroid cartilage — causing permanent pitch lowering or voice change. This risk is minimised by precise identification of the anterior commissure level before cartilage reduction, using direct or fibreoptic laryngoscopy. The incidence of permanent voice change from chondrolaryngoplasty performed by experienced surgeons is under 1–2%.

More common complications include swelling and bruising of the anterior neck (expected, resolving within one to two weeks), seroma or haematoma formation (2–5%), wound infection (1–3%), and temporary dysphagia or odynophagia from surgical dissection near the hyoid and suprahyoid muscles. Palpable cartilage irregularity or asymmetry from uneven reduction may occur but is rarely symptomatic. Keloid or hypertrophic scarring at the neck incision affects 1–3% of patients and is more common in darker skin phototypes. Hypothyroid patients may experience altered wound healing from disruption to perithyroidal tissues, though the thyroid gland itself is not entered during the procedure.

Patients are typically discharged on the day of surgery or following an overnight observation. A soft diet is recommended for the first three to five days while oropharyngeal and neck swelling resolves. Patients are advised to avoid strenuous activity, neck hyperextension, and heavy lifting for two weeks. Voice rest for forty-eight to seventy-two hours post-operatively reduces cord oedema. Wound dressings are removed at forty-eight hours, and wounds are supported with micropore tape for four to six weeks to minimise scar widening.

A follow-up appointment at one to two weeks checks wound healing, swallowing function, and voice quality. Laryngoscopy at six weeks confirms vocal cord mobility and integrity. Scar maturation is assessed at three and six months; treatments including silicone gel, laser therapy, or scar massage are initiated if hypertrophic scarring develops. Most patients return to office work within five to seven days and full physical activity within two weeks. Long-term results are assessed at six to twelve months when scar maturation and final cartilage contour are established.

Chondrolaryngoplasty in the United States costs approximately $4,000–$8,000 when performed as a standalone procedure, and may be partially covered by insurance in some US states with gender-affirming surgery mandates. When combined with other facial feminisation procedures, the overall FFS package cost ranges from $20,000 to $50,000. In the United Kingdom under private care, tracheal shave costs approximately £2,500–£5,000; NHS coverage is available for gender-affirming procedures through gender clinics, though waiting lists are extensive.

Facial feminisation surgery including tracheal shave is widely available at specialist centres in Thailand — a globally recognised hub for gender-affirming surgery — at $1,500–$3,000 for the isolated procedure, or as part of comprehensive FFS packages costing $10,000–$25,000. South Korea and Mexico also have established gender-affirming surgery centres offering chondrolaryngoplasty at significantly lower costs than Western countries. India offers the procedure at $800–$2,000 at specialist maxillofacial and ENT centres with experience in facial feminisation.

Non-surgical alternatives for reducing the visual impact of a prominent Adams apple include contouring makeup and strategic clothing choices (high-necked garments, scarves), which provide temporary concealment without addressing the underlying anatomy. Neck positioning and hairstyle can reduce visibility in social settings. These approaches provide no permanent anatomical change.

For transgender women, voice feminisation therapy with a speech-language pathologist specialising in transgender voice provides acoustic feminisation (raising pitch, altering resonance and intonation) without surgery, complementing or replacing surgical voice feminisation (Wendler glottoplasty) in cases where voice pitch is the primary concern rather than neck anatomy. Comprehensive facial feminisation addresses multiple features of facial masculinity simultaneously — forehead bossing, orbital rim, rhinoplasty, jaw and chin — and the decision to include chondrolaryngoplasty is individualised based on the degree of thyroid cartilage prominence and the patient's priorities.